Recent Synthetic and Biological Developments on 1,2,4‐Triazolopyrimidines
Open Access
- 4 September 2023
- journal article
- review article
- Published by Wiley in ChemistrySelect
- Vol. 8 (33)
Abstract
1,2,4‐Triazolopyrimidines scaffold spaciously acknowledged with anticancer, antimalarial, antitubercular and many other fascinating biological applications in recent years (2015–2022). Moreover, numerous mild synthetic methodologies reported, which has been summarized as (i) condensation of 2‐amino‐1,2,4‐triazole or 5‐amino‐1,2,4‐triazole with 1,3‐dielectrophilic equivalents like 1,3‐diketones, β‐ketoester (ii) oxidative‐cyclization of hydrazones or related analogues. This review would flourish the synthetic and medicinal chemist to design more bioactive 1,2,4‐triazolopyrimidines molecules for drug development with enhanced binding interactions, structural features with the help discussed SAR and cost effective methodologies in the coming years.Keywords
This publication has 113 references indexed in Scilit:
- Characterization of Resistance to the Nonnucleoside NS5B Inhibitor Filibuvir in Hepatitis C Virus-Infected PatientsAntimicrobial Agents and Chemotherapy, 2012
- The impact of uptake, translocation and metabolism on the differential selectivity between blackgrass and wheat for the herbicide pyroxsulamPest Management Science, 2010
- The discovery of the potent aurora inhibitor MK-0457 (VX-680)Bioorganic & Medicinal Chemistry Letters, 2009
- Enzymology of Purine and Pyrimidine Antimetabolites Used in the Treatment of CancerChemical Reviews, 2009
- Blocking Estrogen Signaling After the Hormone: Pyrimidine-Core Inhibitors of Estrogen Receptor-Coactivator BindingJournal of Medicinal Chemistry, 2008
- TTI-237: A Novel Microtubule-Active Compound with In vivo Antitumor ActivityCancer Research, 2008
- Essramycin: A First Triazolopyrimidine Antibiotic Isolated from Nature†The Journal of Antibiotics, 2008
- Pyrimidine as Constituent of Natural Biologically Active CompoundsChemistry & Biodiversity, 2005
- Synthesis and Biological Activity of Methanesulfonamide Pyrimidine- and N-Methanesulfonyl Pyrrole-Substituted 3,5-Dihydroxy-6-heptenoates, a Novel Series of HMG-CoA Reductase InhibitorsBioorganic & Medicinal Chemistry, 1997
- Phenylamino-pyrimidine (PAP) — derivatives: a new class of potent and highly selective PDGF-receptor autophosphorylation inhibitorsBioorganic & Medicinal Chemistry Letters, 1996